Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | Director | Common shares without par value | 6.73M | $797M | $118.50 | Apr 26, 2024 | Direct |
ABBOTT LABORATORIES | Director | Common shares without par value | 258 | $30.6K | $118.50 | Apr 26, 2024 | Alynne Starks 2012 Irrevocable Trust |
ABBOTT LABORATORIES | Director | Option (right to buy) | 5.28K | Apr 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Apr 26, 2024 | 2 | $0 | 4 | Apr 30, 2024 | Director |
ABT | ABBOTT LABORATORIES | Oct 26, 2023 | 2 | -$4.7M | 4 | Oct 30, 2023 | Director |
ABT | ABBOTT LABORATORIES | Jul 27, 2023 | 2 | -$5.69M | 4 | Jul 28, 2023 | Director |
ABT | ABBOTT LABORATORIES | Apr 28, 2023 | 4 | -$5.55M | 4 | May 2, 2023 | Director |
ABT | ABBOTT LABORATORIES | Oct 27, 2022 | 2 | -$4.87M | 4 | Oct 31, 2022 | Director |
ABT | ABBOTT LABORATORIES | Jul 26, 2022 | 2 | -$5.46M | 4 | Jul 28, 2022 | Director |
ABT | ABBOTT LABORATORIES | May 3, 2022 | 3 | -$5.66M | 4 | May 5, 2022 | Director |
ABT | ABBOTT LABORATORIES | Apr 29, 2022 | 1 | $0 | 4 | May 3, 2022 | Director |